Citation Impact
Citing Papers
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
The Lymphatic System in Body Homeostasis: Physiological Conditions
2003
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
2001 Standout
The Roland–Morris Disability Questionnaire and the Oswestry Disability Questionnaire
2000 Standout
Interventions for preventing bone disease in kidney transplant recipients: A systematic review of randomized controlled trials
2005
Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation
2004
Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice
2013 Standout
Whole Body Composition of Rats Determined by Dual Energy X-Ray Absorptiometry Is Correlated with Chemical Analysis
1998
Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment
1996
Effects of a ‘Common Sense Diet’ on Urinary Composition and Supersaturation in Patients with Idiopathic Calcium Urolithiasis
1999
Abnormal Bone and Mineral Metabolism in Kidney Transplant Patients – A Review
2007
Kidney stones: pathophysiology and medical management
2006 Standout
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
Pamidronate
1992
Bisphosphonates: A New Class of Drugs in Diseases of Bone and Calcium Metabolism
1989
Distinct β-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation
2006 StandoutNobel
The Role of Calcitonin in the Development and Treatment of Osteoporosis*
1987
Pamidronate infusions as single-agent therapy for bone metastases: A phase II trial in patients with breast cancer
1995
Extracorporeal shock wave lithotripsy for cystine urolithiasis in children: Outcome and complications
2002
Effects of DeflazacortVersusPrednisone on Bone Mass, Body Composition, and Lipid Profile: A Randomized, Double Blind Study in Kidney Transplant Patients1
1998
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Use of bisphosphonates in cancer patients
1996
Addressing the Musculoskeletal Components of Fracture Risk with Calcium and Vitamin D: A Review of the Evidence
2006
Osteoclast inhibition for the treatment of bone metastases
1993
Risk of Hip Fracture Among Dialysis and Renal Transplant Recipients
2002
Treatment of Tumor-Induced Osteolysis by APD
1989
Vitamin D Deficiency
2007 Standout
Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease
2000
Effect of sex and age on bone mass, body composition and fuel metabolism in humans
1997
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
1993 Standout
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
The Oswestry Disability Index
2000 Standout
Osteoporosis in chronic kidney disease
2004
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
2004 Standout
Markers of bone resorption in patients treated with pamidronate
1998
Idiopathic Calcium Nephrolithiasis
1998
Skeletal remodeling in health and disease
2007 Standout
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
2006 Standout
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
MECHANISM OF STONE FORMATION
1997
Ghrelin induces adiposity in rodents
2000 StandoutNature
Urine Volume: Stone Risk Factor and Preventive Measure
1998
Potassium administration increases and potassium deprivation reduces urinary calcium excretion in healthy adults
1991
Clinical implications of physicochemistry of stone formation
2002
Treatment with Vitamin D and Calcium Reduces Bone Loss after Renal Transplantation
2002
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
1998
Bone mineral density changes within six months of renal transplantation
2003
A Prospective Study of Dietary Calcium and Other Nutrients and the Risk of Symptomatic Kidney Stones
1993 Standout
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
2008 Standout
Na + :HCO 3 − Cotransporters (NBC): Cloning and Characterization
2001
Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis
2013 StandoutNobel
The evolving role of bisphosphonates
2001
Effects of Ingesting Supplements Designed to Promote Lean Tissue Accretion on Body Composition during Resistance Training
1996
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Prevalence and risk factors for osteopenia in dialysis patients
1996
Calcium and Calcitriol Prophylaxis Attenuates Posttransplant Bone Loss
2004
Major Depressive Disorder
2008 Standout
Body-composition assessment via air-displacement plethysmography in adults and children: a review
2002
CA 72-4 Serum Marker–A New Tool in the Management of Carcinoma Patients
1995
The Multifunctional Fish Gill: Dominant Site of Gas Exchange, Osmoregulation, Acid-Base Regulation, and Excretion of Nitrogenous Waste
2004 Standout
Bisphosphonates and bone metastases
1988
Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate
1988
Effects of creatine supplementation on body composition, strength, and sprint performance
1998
No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients
1997
Substitution of three amino acids switches receptor specificity of Gqα to that of Giα
1993 StandoutNatureNobel
Osteoporosis after solid organ and bone marrow transplantation
2003
Sensors and regulators of intracellular pH
2009 Standout
Periosteum: biology, regulation, and response to osteoporosis therapies
2004
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Variations in lipid and apolipoprotein concentrations in human leg lymph: effects of posture and physical exercise
2004
Obesity in children and young people: a crisis in public health
2004 Standout
Bisphosphonates
1991
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression
2007
The rise and rise of drug delivery
2005
Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women
2009 Standout
Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation
2000
Prevention of falls and consequent injuries in elderly people
2005 Standout
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone
2002
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure
1995
Disorders Associated With Acute Rapid and Severe Bone Loss
2003
Quantitative Trait Loci Affecting Peak Bone Mineral Density in Mice
1998
Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone
1992
Aromatase Deficiency in a Female Who Is Compound Heterozygote for Two New Point Mutations in the P450arom Gene: Impact of Estrogens on Hypergonadotropic Hypogonadism, Multicystic Ovaries, and Bone Densitometry in Childhood1
1997
The Lymphatic System: Integral Roles in Immunity
2016 Standout
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Bone Resorption by Osteoclasts
2000 StandoutScience
Long-term Follow-up of Stone Formers Treated with a Low Dose of Sodium Potassium Citrate
2000
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Fracture after cardiac transplantation: a prospective longitudinal study.
1996
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Comparative Study of In Vivo Lymphatic Sealing Capability of the Porcine Thoracic Duct Using Laparoscopic Dissection Devices
2008 StandoutNobel
Molecular physiology and genetics of Na+-independent SLC4 anion exchangers
2009
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Posttransplant Acidosis and Associated Disorders of Mineral Metabolism in Patients With a Renal Graft
2007
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation
2005 Standout
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Mucosal leishmaniasis ("espundia") responsive to low dose of N-methyl glucamine (Glucantime ®) in Rio de Janeiro, Brazil
2000
H+-K+-ATPases: regulation and role in pathophysiological states
1999
Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis
1996
Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
2003
Lymphatic pumping: mechanics, mechanisms and malfunction
2016
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma
1999 Standout
A β-Arrestin–Biased Agonist of the Parathyroid Hormone Receptor (PTH1R) Promotes Bone Formation Independent of G Protein Activation
2009 StandoutNobel
A recombinant calcitonin receptor independently stimulates 3',5'-cyclic adenosine monophosphate and Ca2+/inositol phosphate signaling pathways.
1992
Skeletal complications of malignancy
1997 Standout
Alendronate Prevents Further Bone Loss in Renal Transplant Recipients
2001
Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans: associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency
2000
Bone metabolism and disease in chronic kidney disease
2003
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
Drug Resistance in Leishmaniasis
2006 Standout
Creatine and Creatinine Metabolism
2000 Standout
Independent and interactive effects of preload and afterload on the pump function of the isolated lymphangion
2012
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Prevention of Stone Formation and Bone Loss In Absorptive Hypercalciuria by Combined Dietary and Pharmacological Interventions
2003
Works of P Jaeger being referenced
Dual-energy X-ray absorptiometry for measuring total bone mineral content in the rat: Study of accuracy and precision
1994
Effects of Nasal Calcitonin on Bone Mineral Density following Parathyroidectomy in Patients with Primary Hyperparathyroidism
2003
Incidence and Direct Medical Costs of Hospitalizations due to Osteoporotic Fractures in Switzerland
1997
Body composition and fuel metabolism after kidney grafting
1995
Immunohistochemical comparison of a case of inherited distal renal tubular acidosis (with a unique AE1 mutation) with an acquired case secondary to autoimmune disease
2007
Risk factors for low urinary citrate in calcium nephrolithiasis: low vegetable fibre intake and low urine volume to be added to the list
1994
Altered body composition and fuel metabolism in stable kidney transplant patients on immuno‐suppressive monotherapy with cyclosporine A
1994
Parathyroid hormone directly inhibits tubular reabsorption of bicarbonate in normocalcaemic rats with chronic hyperparathyroidism
1987
Dose-response in the treatment of hypercalcemia of malignancy by a single infusion of the bisphosphonate AHPrBP.
1988
Long-Term Systemic Administration of Human Recombinant Interleukin-1β Induces a Dose-Dependent Fall in Circulating Parathyroid Hormone in Rats
1999
DETECTION OF RECURRENCE OF LARGE-BOWEL CARCINOMA BY RADIOIMMUNOASSAY OF CIRCULATING CARCINOEMBRYONIC ANTIGEN (C.E.A.)
1974
Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation
1993
Impact of hydration status on body composition as measured by dual energy X-ray absorptiometry in normal volunteers and patients on haemodialysis
1992
Animal model of primary hyperparathyroidism
1987
Changes in bone mass early after kidney transplantation
1994
[Respective role of the size, location and composition of the calculus as determinants of therapeutic success after extracorporeal shock wave lithotripsy in renal lithiasis].
1992
Evidence that calcitonin stimulates 1,25-dihydroxyvitamin D production and intestinal absorption of calcium in vivo.
1986
Oral versus intravenous AHPrBP (APD) in the treatment of hypercalcemia of malignancy
1986
Renal tubular acidosis, a side effect of treatment with pentavalent antimony.
1991
A single-day treatment of tumor-induced hypercalcemia by intravenous amino-hydroxypropylidene bisphosphonate
1986
Response to retreatment of malignant hypercalcemia with the bisphosphonate AHPrBP (APD): Respective role of kidney and bone
1990
Renal bicarbonate reabsorption in the rat. II. Distal tubule load dependence and effect of hypokalemia.
1987
Effectiveness of salmon calcitonin administered as suppositories in tumor-induced hypercalcemia
1987
Twenty‐Four Hour Variation in Flow and Composition of Leg Lymph in Normal Men
1977
Paget's disease of bone treated in five days with AHPrBP (APD) per Os
1987
Influence of acute potassium loading on renal phosphate transport in the rat kidney
1983